Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects

NCT02227030 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIIB 722 CL solution
DRUG: BIIB 722 CL tablet
DRUG: Placebo solution
DRUG: Placebo tablet

Sponsor

Boehringer Ingelheim